Business Wire

Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

− GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Now Available by Prescription for Intravenous or Subcutaneous Use in People Aged ...
Monthly Prescribing Reference

Gammagard Liquid ERC Now Available for Primary Immunodeficiency

Credit: Takeda. Gammagard Liquid ERC is supplied as a 10% IgG (100mg/mL) solution of less than or equal to 2µg/mL of IgA. Gammagard Liquid ERC is a ready-to-use, low IgA immunoglobulin therapy that ...
Renal & Urology News

What Is the Role of Immunoglobulins in Patients With Systemic Lupus Erythematosus?

Antibody. Illustration of an immunoglobulin antibody molecule. This Y-shaped molecule has two arms that can bind to specific antigens, for instance viral or bacterial proteins. In doing this it marks ...
Business Wire

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Yahoo Finance

Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

"As the latest addition to our broad IG portfolio, GAMMAGARD LIQUID ERC underscores our ongoing dedication to providing differentiated therapeutic options to meet the varied needs of people with ...